• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
  • Lipocine Receives FDA Clearance for Testing of NASH Candidate americanpharmaceuticalreview
    July 25, 2019
    Lipocine has received clearance from the U.S. Food and Drug Administration (FDA) to clinically investigate LPCN 1144 in an expanded target population of adult male non-alcoholic steatohepatitis (NASH) patients.

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service